The work was 7th online November by the Journal of the American Chemical Society published.

.. The work was 7th online November by the Journal of the American Chemical Society published. – This discovery gives us for the first time, a molecule that targets the wayward RNA at the root of myotonic muscular dystrophy, said Benjamin Miller, the chemist who led the study. This is a first step towards developing a drug – like molecule could perhaps one day be used to treat the disease. This lead molecule provides a framework for moving forward.

The goal is for doctors free MBNL1 in cells so that they, on their normal activities, the building right chloride channels can go central to crucial for normal muscle function belong.By courtesy of to can entire Kaiser Daily HealthPolicyMonitor Report indicate, search the archives and sign up for email delivery in Kaiser Daily Health Policy is Reports strongly supported kaiser network. A free service from of The Henry J. Publish. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Other entries from category "laboratory":

Random entries